Breaking News

Enteris BioPharma Launches Contract Manufacturing Ops

Will offer production of API using microbial expression systems

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enteris BioPharma will begin contract manufacturing within its 32,000 square foot, FDA inspected and cGMP compliant facility in Boonton, NJ. Equipped for the production of API using microbial expression systems, Enteris BioPharma offers pharmaceutical companies a full array of services to meet their manufacturing needs, from pre-clinical to commercial scale. Brian Zietsman, president and CFO of Enteris BioPharma, said, “The initiation of our contract manufacturing business is an important mile...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters